Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: Association with pneumococcal carriage and acute otitis media in young children

Journal of Infectious Diseases

Volumn 184, Issue 5, 2001, Pages 569-576

  Soininen, A ^a   Pursiainen, H ^a   Kilpi, T ^a   Kayhty H ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS POLYSACCHARIDE;

ANTIBODY PRODUCTION; ARTICLE; BACTERIAL MEMBRANE; CHILD; HUMAN; MAJOR CLINICAL STUDY; OTITIS MEDIA; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; CARRIER STATE; CHILD, PRESCHOOL; HUMANS; INFANT; NASOPHARYNX; OTITIS MEDIA WITH EFFUSION; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0035450277     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/322794     Document Type: Article

References (31)

1. The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods
2. Ten-year review of otitis media pathogens
3. Six newly recognized types of Streptococcus pneumoniae
4. Antibody response to pneumococcal vaccination in children younger than 5 years of age
5. Thymus-independent and thymus-dependent responses to polysaccharide antigens
6. Pneumococcal vaccine and otitis media
7. Prevention of otitis media in children by pneumococcal vaccination
8. Pneumococcal carriage and type-specific antibody: Failure of a 14-valent vaccine to reduce carriage in healthy children
9. Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children
10. Efficacy of a pneumococcal conjugate vaccine against acute otitis media
11. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
12. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine
13. Cross-reactions of polysaccharides of staphylococci and streptococci in antipneumococcal and other antisera
14. Immunochemical relations between pneumococcal group 19 and Klebsiella capsular polysaccharides
15. Capsular polysaccharides of non-groupable streptococci that cross-react with pneumococcal group 19
16. Epidemiologic studies of Streptococcus pneumoniae in infants: Antibody response to nasopharyngeal carriage of types 3, 19, and 23
17. Epidemiological studies of Streptococcus pneumoniae in infants: Antibody to types 3, 6, 14, and 23 in the first two years of life
18. Spread of Streptococcus pneumoniae in families: Relation of transfer of S. pneumoniae to incidence of colds and serum antibody
19. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old
20. Bacteriology of acute otitis media in Finnish children during the first two years of life
21. Natural development of antibodies to pneumococcal surface protein A. pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media
22. Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?
23. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children
24. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum lot 89-S
25. Antibody units assigned to anti-pneumococcal serum, lot 89-S
26. Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic
27. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults
28. Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable?
29. Characteristics of an antibody response to pneumococcal capsular polysaccharides in young children with acute otitis media
30. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants
31. Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage